Zhejiang Hisoar Pharmaceutical Co Ltd (002099) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.48 Million ≈ $2.27 Million USD) by net assets (CN¥5.11 Billion ≈ $747.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Zhejiang Hisoar Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.

Zhejiang Hisoar Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2024)

This chart illustrates how Zhejiang Hisoar Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Hisoar Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Hisoar Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Zhejiang Hisoar Pharmaceutical Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Beijing Urban Construction Investment & Development Co Ltd
SHG:600266
0.032x
Sino Wealth Electronic Ltd
SHE:300327
0.034x
ZWSOFT Guangzhou Co Ltd
SHG:688083
0.046x
Cairn Homes PLC
IR:C5H
-0.020x
Wam Leaders Ltd
AU:WLE
0.048x
Nuvoco Vistas Corporation Limited
NSE:NUVOCO
0.057x
Rizhao Port Co Ltd
SHG:600017
0.017x
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
SHG:605016
0.022x

Annual Cash Flow Conversion Efficiency for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024. View 002099 share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥5.13 Billion
≈ $750.95 Million
CN¥174.83 Million
≈ $25.58 Million
0.034x -20.66%
2023-12-31 CN¥5.60 Billion
≈ $819.71 Million
CN¥240.54 Million
≈ $35.20 Million
0.043x +125.81%
2022-12-31 CN¥6.10 Billion
≈ $893.34 Million
CN¥116.09 Million
≈ $16.99 Million
0.019x +13.58%
2021-12-31 CN¥6.11 Billion
≈ $894.62 Million
CN¥102.36 Million
≈ $14.98 Million
0.017x -81.65%
2020-12-31 CN¥5.85 Billion
≈ $856.34 Million
CN¥533.87 Million
≈ $78.12 Million
0.091x -14.72%
2019-12-31 CN¥5.72 Billion
≈ $837.67 Million
CN¥612.40 Million
≈ $89.61 Million
0.107x -27.14%
2018-12-31 CN¥5.39 Billion
≈ $788.81 Million
CN¥791.45 Million
≈ $115.81 Million
0.147x +635.28%
2017-12-31 CN¥5.14 Billion
≈ $752.44 Million
CN¥102.68 Million
≈ $15.02 Million
0.020x -84.87%
2016-12-31 CN¥4.77 Billion
≈ $698.05 Million
CN¥629.42 Million
≈ $92.10 Million
0.132x +2.00%
2015-12-31 CN¥3.57 Billion
≈ $522.81 Million
CN¥462.16 Million
≈ $67.63 Million
0.129x +114.65%
2014-12-31 CN¥3.18 Billion
≈ $465.15 Million
CN¥191.56 Million
≈ $28.03 Million
0.060x -37.33%
2013-12-31 CN¥632.80 Million
≈ $92.60 Million
CN¥60.85 Million
≈ $8.90 Million
0.096x -60.73%
2012-12-31 CN¥738.05 Million
≈ $108.00 Million
CN¥180.73 Million
≈ $26.45 Million
0.245x +94.84%
2011-12-31 CN¥736.96 Million
≈ $107.84 Million
CN¥92.62 Million
≈ $13.55 Million
0.126x -55.67%
2010-12-31 CN¥638.04 Million
≈ $93.36 Million
CN¥180.88 Million
≈ $26.47 Million
0.283x +61.88%
2009-12-31 CN¥561.79 Million
≈ $82.21 Million
CN¥98.38 Million
≈ $14.40 Million
0.175x +213.25%
2008-12-31 CN¥547.50 Million
≈ $80.12 Million
CN¥30.61 Million
≈ $4.48 Million
0.056x -41.18%
2007-12-31 CN¥538.06 Million
≈ $78.73 Million
CN¥51.14 Million
≈ $7.48 Million
0.095x -20.24%
2006-12-31 CN¥519.27 Million
≈ $75.99 Million
CN¥61.88 Million
≈ $9.06 Million
0.119x -39.55%
2005-12-31 CN¥182.96 Million
≈ $26.77 Million
CN¥36.07 Million
≈ $5.28 Million
0.197x -38.55%
2004-12-31 CN¥132.03 Million
≈ $19.32 Million
CN¥42.36 Million
≈ $6.20 Million
0.321x +600.11%
2003-12-31 CN¥85.03 Million
≈ $12.44 Million
CN¥-5.45 Million
≈ $-798.23K
-0.064x --

About Zhejiang Hisoar Pharmaceutical Co Ltd

SHE:002099 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.27 Billion
CN¥8.68 Billion CNY
Market Cap Rank
#7913 Global
#1802 in China
Share Price
CN¥5.36
Change (1 day)
-0.74%
52-Week Range
CN¥4.98 - CN¥8.83
All Time High
CN¥11.31
About

Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and dyes in China and internationally. The company offers antibiotics, cardiovascular, hypoglycemic, fine chemicals, formulations, intermediates, and other products. It also provides dyestuff, and intermediates of dyestuff and pigment; and manufactures environmental protection related equipment, medical… Read more